Literature DB >> 27157445

Prediction of Protein Aggregation in High Concentration Protein Solutions Utilizing Protein-Protein Interactions Determined by Low Volume Static Light Scattering.

Melanie Hofmann1, Matthias Winzer2, Christian Weber2, Henning Gieseler3.   

Abstract

The development of highly concentrated protein formulations is more demanding than for conventional concentrations due to an elevated protein aggregation tendency. Predictive protein-protein interaction parameters, such as the second virial coefficient B22 or the interaction parameter kD, have already been used to predict aggregation tendency and optimize protein formulations. However, these parameters can only be determined in diluted solutions, up to 20 mg/mL. And their validity at high concentrations is currently controversially discussed. This work presents a μ-scale screening approach which has been adapted to early industrial project needs. The procedure is based on static light scattering to directly determine protein-protein interactions at concentrations up to 100 mg/mL. Three different therapeutic molecules were formulated, varying in pH, salt content, and addition of excipients (e.g., sugars, amino acids, polysorbates, or other macromolecules). Validity of the predicted aggregation tendency was confirmed by stability data of selected formulations. Based on the results obtained, the new prediction method is a promising screening tool for fast and easy formulation development of highly concentrated protein solutions, consuming only microliter of sample volumes.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interaction; light scattering (static); physical stability; preformulation; protein; protein aggregation; protein formulation

Mesh:

Substances:

Year:  2016        PMID: 27157445     DOI: 10.1016/j.xphs.2016.03.022

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

2.  Quantitative characterization of bovine serum albumin thin-films using terahertz spectroscopy and machine learning methods.

Authors:  Yiwen Sun; Pengju Du; Xingxing Lu; Pengfei Xie; Zhengfang Qian; Shuting Fan; Zexuan Zhu
Journal:  Biomed Opt Express       Date:  2018-06-06       Impact factor: 3.732

3.  Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development.

Authors:  Martin Domnowski; Jan Jaehrling; Wolfgang Frieß
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

4.  An accelerated surface-mediated stress assay of antibody instability for developability studies.

Authors:  Marie R G Kopp; Adriana-Michelle Wolf Pérez; Marta Virginia Zucca; Umberto Capasso Palmiero; Brigitte Friedrichsen; Nikolai Lorenzen; Paolo Arosio
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

Review 5.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.